Synopsis
Synopsis
0
JDMF
0
EU WC
0
KDMF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Fradizine
2. Hydrochloride, Tylosin
3. Tartrate, Tylosin
4. Tylan
5. Tylosin
6. Tylosin Hydrochloride
7. Tylosin Tartrate
8. Tylosin Tartrate (salt)
9. Tylosine
1. Pharmasin
2. Tylosin Tartrate
3. 1405-54-5
4. Schembl14973663
| Molecular Weight | 1066.2 g/mol |
|---|---|
| Molecular Formula | C50H83NO23 |
| Hydrogen Bond Donor Count | 9 |
| Hydrogen Bond Acceptor Count | 24 |
| Rotatable Bond Count | 16 |
| Exact Mass | 1065.53558789 g/mol |
| Monoisotopic Mass | 1065.53558789 g/mol |
| Topological Polar Surface Area | 354 Ų |
| Heavy Atom Count | 74 |
| Formal Charge | 0 |
| Complexity | 1700 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 21 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 2 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)

API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
97
PharmaCompass offers a list of Tylosin Tartrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tylosin Tartrate manufacturer or Tylosin Tartrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tylosin Tartrate manufacturer or Tylosin Tartrate supplier.
PharmaCompass also assists you with knowing the Tylosin Tartrate API Price utilized in the formulation of products. Tylosin Tartrate API Price is not always fixed or binding as the Tylosin Tartrate Price is obtained through a variety of data sources. The Tylosin Tartrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Tylosine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tylosine, including repackagers and relabelers. The FDA regulates Tylosine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tylosine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tylosine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tylosine supplier is an individual or a company that provides Tylosine active pharmaceutical ingredient (API) or Tylosine finished formulations upon request. The Tylosine suppliers may include Tylosine API manufacturers, exporters, distributors and traders.
click here to find a list of Tylosine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Tylosine DMF (Drug Master File) is a document detailing the whole manufacturing process of Tylosine active pharmaceutical ingredient (API) in detail. Different forms of Tylosine DMFs exist exist since differing nations have different regulations, such as Tylosine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Tylosine DMF submitted to regulatory agencies in the US is known as a USDMF. Tylosine USDMF includes data on Tylosine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Tylosine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Tylosine suppliers with USDMF on PharmaCompass.
A Tylosine CEP of the European Pharmacopoeia monograph is often referred to as a Tylosine Certificate of Suitability (COS). The purpose of a Tylosine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Tylosine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Tylosine to their clients by showing that a Tylosine CEP has been issued for it. The manufacturer submits a Tylosine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Tylosine CEP holder for the record. Additionally, the data presented in the Tylosine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Tylosine DMF.
A Tylosine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Tylosine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Tylosine suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Tylosine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Tylosine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Tylosine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Tylosine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Tylosine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Tylosine suppliers with NDC on PharmaCompass.
Tylosine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tylosine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tylosine GMP manufacturer or Tylosine GMP API supplier for your needs.
A Tylosine CoA (Certificate of Analysis) is a formal document that attests to Tylosine's compliance with Tylosine specifications and serves as a tool for batch-level quality control.
Tylosine CoA mostly includes findings from lab analyses of a specific batch. For each Tylosine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tylosine may be tested according to a variety of international standards, such as European Pharmacopoeia (Tylosine EP), Tylosine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tylosine USP).